Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 6:13:1283431.
doi: 10.3389/fonc.2023.1283431. eCollection 2023.

Editorial: Reviews in radiation oncology

David Y Lee  1 , Ganapasam Sudhandiran  2 , Sunil D Sharma  3
Affiliations
Editorial

Editorial: Reviews in radiation oncology

David Y Lee et al. Front Oncol. .
No abstract available

Keywords: HDAC inhibitor; PET/MRI; PSMA; cardiac implantable electronic device (CIED); meningioma; nasopharynx; oligometastasis; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Reviews in radiation oncology

References

    1. Gruen A, Tegel K, Kluge A, Budach V, Zips D, Boehmer D. PSMA PET-based stereotactic body radiotherapy for locally recurrent prostate cancer after definitive first-line therapy. Prostate (2023) 83(13):1298–305. doi: 10.1002/pros.24592 - DOI - PubMed
    1. Parker CC, James ND, Brawley CD, Clarke NW, Ali A, Amos CL, et al. . Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PloS Med (2022) 19(6):e1003998. doi: 10.1371/journal.pmed.1003998 - DOI - PMC - PubMed
    1. Flygare L, Erdogan ST, Soderkvist K. PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer. Acta Radiol (2023) 64(5):1865–72. doi: 10.1177/02841851221140668 - DOI - PMC - PubMed
    1. Liu LL, Zhu LL, Lu ZG, Sun JD, Zhao J, Wang HF, et al. . Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer. Cancer Imaging (2023) 23(1):1. doi: 10.1186/s40644-022-00518-7 - DOI - PMC - PubMed
    1. Yoo J, Lee JM, Joo I, Lee DH, Yoon JH, Yu MH, et al. . Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, (18)F-FDG PET/MRI and CA 19-9. Cancer Imaging (2023) 23(1):49. doi: 10.1186/s40644-023-00565-8 - DOI - PMC - PubMed

Publication types